Drugs / NX1011
last change May 2007 re-read 3 minutes ago

NX1011

Developed for
pulmonary hypertension
Investigated by
NITROX, LLC

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00323024 Sep 2006 → May 2007 pulmonary hypertension NITROX, LLC Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NX1011 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00323024 ↗
Route Inhaled “inhaled NX1011” NCT00323024 ↗